F.C. Muñoz Casares-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations

    Cancers, Vol. 16, Núm. 15

2023

  1. Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)

    Journal of Clinical Medicine, Vol. 12, Núm. 11

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

2020

  1. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2017

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

  1. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study

    Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116

2009

  1. Ovarian peritoneal mucinous carcinomatosis and pseudomyxoma peritonei of ovarian origin. Are they the same?

    Cirugía española, Vol. 85, Núm. 1, pp. 55-57